FIELD: medicine, ophthalmology, pharmacy. SUBSTANCE: method involves the use of mesatone, epinephrine, atropine solutions in viscoprotecting agent. Mesatone 0.001-1% solution or epinephrine 0.001-0.01% is administrated into eye an aqueous chamber and mesatone or atropine 0.01-2% or epinephrine 0.01-0.1% solution is dropped into conjunctival cavity of eye. EFFECT: enhanced effectiveness of mydriasis. 2 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR MEDICINAL PUPIL OF EYE MYDRIASIS IN OPHTHALMOLOGY | 1999 |
|
RU2148404C1 |
PHARMACEUTICAL COMPOSITION "POLYANESTHETIC" FOR PROLONGED ANESTHETIZATION IN OPHTHALMOLOGY | 2001 |
|
RU2183114C1 |
METHOD FOR ACHIEVING MYDRIASIS TO CARRY OUT PHACOEMULSIFICATION IN THE CASES OF CONGENITAL IRIS COLOBOMA | 2004 |
|
RU2259182C1 |
PHARMACEUTICAL COMPOSITION FOR PROPHYLAXIS OF OPHTHALMOLOGICAL INFECTIONS | 2004 |
|
RU2284181C2 |
IRRIGATIVE COMPOSITION "GIDROELASTIC" FOR INTRAOCULAR APPLICATION | 2001 |
|
RU2212883C2 |
METHOD FOR IMPROVING VISUAL FUNCTIONS AFTER SURGICAL CATARACT TREATMENT WITH ARTIFICIAL INTRAOCULAR LENS BEING IMPLANTED AND AGGRAVATED BY EXUDATIVE RESPONSE | 2003 |
|
RU2253413C1 |
METHOD FOR IMPLANTING ARTIFICIAL LENS | 1996 |
|
RU2135130C1 |
METHOD OF DRUG DILATION OF RIGID PUPIL BEFORE PERFORMING PHACOEMULSIFICATION | 2013 |
|
RU2525512C1 |
PHARMACEUTICAL COMPOSITION FOR ANESTHESIA IN OPHTHALMOLOGY | 1999 |
|
RU2147876C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING CORNEAL EDEMAS | 2001 |
|
RU2197923C1 |
Authors
Dates
2001-08-20—Published
1998-10-29—Filed